Peer-reviewedCC BY 4.0Journal of cellular signaling7 Nov 2026

Glucagon-like Peptide-1 Receptor Agonists in Treating Diabetes Mellitus and Weight Loss with Potential Application to Rare Obesity-related Genetic Disorders: A Commentary

Lucas Francis¹
Merlin G. Butler²

¹Kansas City University College of Osteopathic Medicine, Kansas City, MO 64106, USA
²Departments of Psychiatry & Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, KS 66160, USA

Glucagon-Like Peptide-1 Receptor Agonist and Gastrointestinal Adverse Effects: A Comprehensive Review Efectos adversos gastrointestinales del agonista del receptor de GLP-1: revisión narrativa
Julio Zúñiga Cisneros, Michael Camilleri, Madhusudan Grover
Acta gastroenterologica Latinoamericana16 Oct 2026Peer-reviewedCC BY-NC-SAFull textGeneral medicineEurope PMC
De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review
Wares Jalil
Cureus19 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention
Alaa Solaiman Algazzar
Saudi Journal of Internal Medicine1 Sep 2026Peer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismDOAJ
Divergent ocular safety profiles of glucagon-like peptide-1 receptor agonists: a pharmacological heterogeneity framework
Huili Li, Shengke Peng, Daoxi Lei
Frontiers in medicine16 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
Audrey Y. Chang, Farrah J. Mateen
Annals of clinical and translational neurology12 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{francis2026glucagonlike,
  title = {{Glucagon-like Peptide-1 Receptor Agonists in Treating Diabetes Mellitus and Weight Loss with Potential Application to Rare Obesity-related Genetic Disorders: A Commentary}},
  author = {Lucas Francis and Merlin G. Butler},
  journal = {Journal of cellular signaling},
  year = {2026},
  month = nov,
  doi = {10.33696/signaling.7.153},
  url = {https://doi.org/10.33696/signaling.7.153},
  note = {CC BY 4.0},
}

RIS

TY  - JOUR
TI  - Glucagon-like Peptide-1 Receptor Agonists in Treating Diabetes Mellitus and Weight Loss with Potential Application to Rare Obesity-related Genetic Disorders: A Commentary
AU  - Lucas Francis
AU  - Merlin G. Butler
PY  - 2026
DA  - 2026/11/07
JO  - Journal of cellular signaling
DO  - 10.33696/signaling.7.153
UR  - https://doi.org/10.33696/signaling.7.153
SN  - 2692-0638
ER  -

Related

Cite